Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Vorasidenib generate over $100 million in revenue by Q4 2024?  | Binary | 3 | 5 months ago | ||
Will Vorasidenib be adopted by at least 50% of oncologists for low-grade glioma by end of 2024? | Binary | 2 | 5 months ago | ||
Will Vorasidenib be approved in the EU by August 7, 2025? | Binary | 2 | 5 months ago | ||
What will be the market share of Vorasidenib among IDH-mutant glioma treatments by end of 2024? | Categorical | 2 | 5 months ago | ||
How many prescriptions for Vorasidenib will be issued by end of 2024? | Categorical | 2 | 5 months ago | ||
What will be the next major development in glioma treatments by August 7, 2025? | Categorical | 2 | 5 months ago |